Burcon NutraScience Corporation
BRCNF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 1.31 | -0.16 | -0.16 |
| FCF Yield | -39.77% | -0.82% | -1.06% | -0.29% |
| EV / EBITDA | -4.00 | -106.80 | -82.60 | -324.45 |
| Quality | ||||
| ROIC | -26.24% | -59.39% | -80.84% | -26.05% |
| Gross Margin | -228.31% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.67 | 0.78 | 0.24 | 0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.58% | 2.45% | 12.05% | 76.60% |
| Free Cash Flow Growth | 1.49% | 6.92% | 11.23% | -24.27% |
| Safety | ||||
| Net Debt / EBITDA | -2.03 | -0.37 | -0.51 | 0.93 |
| Interest Coverage | -13.94 | -13.72 | -16.14 | -65.19 |
| Efficiency | ||||
| Inventory Turnover | 6.23 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -207.12 | 266.50 | 333.11 | 426.46 |